Home Page
-
Vanderbilt chemist Ben Brown awarded $2.375M to develop nonaddictive painkillers with AI
Avenir Award funding from the National Institute on Drug Abuse recognizes research that represents “the future of addiction science.” Brown’s research is creating an AI-experiment feedback loop that will help optimize painkilling drugs to be less addictive. Read MoreJan. 19, 2024
-
First successful clinical trial of VU319 brings Alzheimer’s treatment one step closer
Phase I clinical trial of a drug was successfully completed at the Warren Center for Neuroscience Drug Discovery, with promise to treat Alzheimer’s and other neurodegenerative diseases. The compound, named VU319, is the first Vanderbilt end-to-end drug discovery effort related to memory loss, starting from the earliest basic science research through human clinical trials. Read MoreJan. 19, 2024
-
OpenFold authority Mohammed AlQuraishi, Columbia University, to deliver Apex Lecture on January 29
Machine learning and OpenFold authority Mohammed AlQuraishi to present the Vanderbilt Basic Sciences Apex Lecture on January 29. Read MoreJan. 17, 2024
-
Lab-to-Table Conversation: Beyond Addiction: Therapeutic Developments and Societal Impact, on Jan. 24
Join the next Lab-to-Table conversation, “Beyond Addiction: Therapeutic Developments and Societal Impact” on Jan. 24 at 11:30 a.m. CT. Read MoreJan. 11, 2024
-
Innovation Ignition Fund launches a pilot program to support early-stage therapeutic projects with translational viability
The School of Medicine Basic Sciences and the Office of the Vice Provost for Research and Innovation launch the Innovation Ignition Fund. This pilot program offers up to $500,000 in funding and drug development mentorship from Vanderbilt scientists with expertise in translational research. Read MoreJan. 8, 2024
-
Harnessing a key growth pathway to reprogram tumor-associated macrophages
Researchers in the lab of Vivian Weiss, assistant professor of pathology, microbiology, and immunology, recently published a review article in Cancer Research that describes the role of the Wnt pathway in TAMs and tumor biology. Read MoreJan. 3, 2024
-
Study uses new tools, machine learning to investigate major cause of blindness in older adults
An international collaboration led by Vanderbilt researchers has identified a key component in lesions associated with age-related macular degeneration (AMD), a leading cause of blindness in older adults. Read MoreDec. 20, 2023
-
Anti-aging researcher Monica Driscoll, Rutgers University, to present Apex Lecture on January 8
Anti-aging researcher and National Academy of Sciences member Monica Driscoll (Rutgers University) to deliver the Vanderbilt Basic Sciences Apex Lecture. Read MoreDec. 14, 2023
-
-
Quanta Magazine: She Studies How Addiction Hijacks Learning in the Brain
Erin Calipari works to understand how drugs like opioids and cocaine alter learning circuits and neurochemistry in one of the country's epicenters of substance use disorder and addiction. Read MoreDec. 13, 2023